{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:56:21Z","timestamp":1740149781795,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12328-019-01064-9","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T14:03:25Z","timestamp":1573135405000},"page":"372-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A case of small bowel adenocarcinoma wherein nivolumab conferred temporary benefit in disease control"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-2832","authenticated-orcid":false,"given":"Kazutaka","family":"Iijima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuharu","family":"Oozeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Fujieda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoaki","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhide","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Amagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"key":"1064_CR1","first-page":"243","volume":"7","author":"AI Neugut","year":"1998","unstructured":"Neugut AI, Jacobson JS, Suh S, et al. The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev. 1998;7:243\u201351.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1064_CR2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/ije\/25.4.722","volume":"25","author":"JS Chow","year":"1996","unstructured":"Chow JS, Chen CC, Ahsan H, et al. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973\u20131990. Int J Epidemiol. 1996;25:722\u20138.","journal-title":"Int J Epidemiol"},{"key":"1064_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","volume":"249","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Wayne JD, et al. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249:63\u201371.","journal-title":"Ann Surg"},{"key":"1064_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.4251\/wjgo.v8.i6.509","volume":"8","author":"S Shenoy","year":"2016","unstructured":"Shenoy S. Genetic risks and familial associations of small bowel carcinoma. World J Gastrointest Oncol. 2016;8:509\u201319.","journal-title":"World J Gastrointest Oncol."},{"key":"1064_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.dld.2013.04.013","volume":"46","author":"T Aparicio","year":"2014","unstructured":"Aparicio T, Zaanan A, Svrcek M, et al. Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Dig Liver Dis. 2014;46:97\u2013104.","journal-title":"Dig Liver Dis."},{"key":"1064_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ajg.2014.435","volume":"110","author":"S Syngal","year":"2015","unstructured":"Syngal S, Brand RE, Church JM, American College of Gastroenterology, et al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223\u201362.","journal-title":"Am J Gastroenterol."},{"issue":"06","key":"1064_CR7","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1053\/gast.2000.20228","volume":"119","author":"FM Giardiello","year":"2000","unstructured":"Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz\u2013Jeghers syndrome. Gastroenterology. 2000;119(06):1447\u201353.","journal-title":"Gastroenterology"},{"issue":"17","key":"1064_CR8","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJMra071600","volume":"357","author":"PH Green","year":"2007","unstructured":"Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357(17):1731\u201343.","journal-title":"N Engl J Med"},{"key":"1064_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.gtc.2016.04.004","volume":"45","author":"T Aparicio","year":"2016","unstructured":"Aparicio T, Zaanan A, Mary F, et al. Small bowel adenocarcinoma. Gastroenterol Clin North Am. 2016;45:447\u201357.","journal-title":"Gastroenterol Clin North Am"},{"key":"1064_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/1940-6207.CAPR-10-0345","volume":"4","author":"H Hampel","year":"2011","unstructured":"Hampel H, de la Chapelle A. The search for unaffected individuals with Lynch syndrome: do the ends justify the means? Cancer Prev Res (Phila). 2011;4:1\u20135.","journal-title":"Cancer Prev Res (Phila)."},{"key":"1064_CR11","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","volume":"5","author":"MD Kappelman","year":"2007","unstructured":"Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn\u2019s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1064_CR12","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1111\/j.1572-0241.2006.00854.x","volume":"101","author":"C Lepage","year":"2006","unstructured":"Lepage C, Bouvier AM, Manfredi S, et al. Incidence and management of primary malignant small bowel cancers: a well-defined French population study. Am J Gastroenterol. 2006;101:2826\u201332.","journal-title":"Am J Gastroenterol"},{"key":"1064_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/jjco\/hyn122","volume":"39","author":"SH Hong","year":"2009","unstructured":"Hong SH, Koh YH, Rho SY, et al. Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome. Jpn J Clin Oncol. 2009;39:54\u201361.","journal-title":"Jpn J Clin Oncol."},{"key":"1064_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00280-017-3371-0","volume":"80","author":"K Takayoshi","year":"2017","unstructured":"Takayoshi K, Kusaba H, Uenomachi M, et al. Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer. Cancer Chemother Pharmacol. 2017;80:333\u201342.","journal-title":"Cancer Chemother Pharmacol."},{"key":"1064_CR15","doi-asserted-by":"crossref","unstructured":"Howe JR, Karnell LH, Menck HR, et al. Adenocarcinoma of the small bowel: review of the National Cancer Data Base. Cancer 1985-1995;86:2693\u20132706.","DOI":"10.1002\/(SICI)1097-0142(19991215)86:12<2693::AID-CNCR14>3.0.CO;2-U"},{"key":"1064_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.amjsurg.2009.05.037","volume":"199","author":"TR Halfdanarson","year":"2010","unstructured":"Halfdanarson TR, McWilliams RR, Donohue JH, et al. A single-institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg. 2010;199:797\u2013803.","journal-title":"Am J Surg"},{"key":"1064_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/cncr.20404","volume":"101","author":"BS Dabaja","year":"2004","unstructured":"Dabaja BS, Suki D, Pro B, et al. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101:518\u201326.","journal-title":"Cancer"},{"key":"1064_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12262-012-0598-1","volume":"75","author":"P Umman","year":"2013","unstructured":"Umman P, Adiyodi V, Narayan C. Small bowel adenocarcinoma\u2014report of two cases and review of literature. Indian J Surg. 2013;75:123\u20137.","journal-title":"Indian J Surg."},{"key":"1064_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/jjco\/hyn122","volume":"39","author":"SH Hong","year":"2009","unstructured":"Hong SH, Koh YH, Rho SY, et al. Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome. Jpn J Clin Oncol. 2009;39:54\u201361.","journal-title":"Jpn J Clin Oncol"},{"key":"1064_CR20","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3892\/ol.2014.1919","volume":"7","author":"K Schwameis","year":"2014","unstructured":"Schwameis K, Schoppmann SF, Stift J, et al. Small bowel adenocarcinoma\u2014terra incognita: a demand for cross-national pooling of data. Oncol Lett. 2014;7:1613\u20137.","journal-title":"Oncol Lett."},{"key":"1064_CR21","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1080\/00365521.2017.1356932","volume":"52","author":"G Lech","year":"2017","unstructured":"Lech G, Korcz W, Kowalczyk E, et al. Primary small bowel adenocarcinoma: current view on clinical features, prognostic factors, treatment and outcome. Scand J Gastroenterol. 2017;52:1194\u2013202.","journal-title":"Scand J Gastroenterol"},{"key":"1064_CR22","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1200\/JCO.2008.19.7145","volume":"27","author":"MJ Overman","year":"2009","unstructured":"Overman MJ, Varadhachary GR, Kopetz S, et al. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol. 2009;27:2598\u2013603.","journal-title":"J Clin Oncol"},{"key":"1064_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/CAD.0b013e328350dd0d","volume":"23","author":"XJ Xiang","year":"2012","unstructured":"Xiang XJ, Liu YW, Zhang L, et al. A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma. Anticancer Drugs. 2012;23:561\u20136.","journal-title":"Anticancer Drugs"},{"key":"1064_CR24","doi-asserted-by":"crossref","unstructured":"Clinical Practice Guidelines in Oncology Colon cancer version 1.2019-March 15,2019. (\nhttps:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf\n\n). Accessed 2019 March 28.","DOI":"10.22233\/20412495.0319.1"},{"key":"1064_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00280-017-3371-0","volume":"80","author":"T Kotoe","year":"2017","unstructured":"Kotoe T, et al. Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer. Cancer Chemother Pharmacol. 2017;80:333\u201342.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1064_CR26","doi-asserted-by":"publisher","first-page":"277e26","DOI":"10.1634\/theoncologist.2017-0568","volume":"23","author":"P Gulhati","year":"2018","unstructured":"Gulhati P, Raghav K, Shroff R, et al. Phase II study of panitumumab in RAS wild-type metastatic adenocarcinoma of small bowel or ampulla of Vater. Oncologist. 2018;23:277e26.","journal-title":"Oncologist."},{"key":"1064_CR27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/(SICI)1096-9098(199804)67:4<216::AID-JSO2>3.0.CO;2-B","volume":"67","author":"E Otsuji","year":"1998","unstructured":"Otsuji E, Yamaguchi T, Sawai K, et al. Characterization of signet ring cell carcinoma of the stomach. J Surg Oncol. 1998;67:216\u201320.","journal-title":"J Surg Oncol"},{"key":"1064_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5833\/jjgs.39.16","volume":"39","author":"T Makino","year":"2006","unstructured":"Makino T, Mishima H, Ikenaga M, et al. Clinicopathologic features of signet-ring cell carcinoma of the colon and rectum. Jpn J Gastroenterol Surg. 2006;39:16\u201322.","journal-title":"Jpn J Gastroenterol Surg."},{"issue":"2","key":"1064_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.tjog.2018.02.025","volume":"57","author":"An-Chieh Liu","year":"2018","unstructured":"Liu An-Chieh, Chen Ch, et al. A rare Krukenberg tumor arising from a primary adenocarcinoma of the small intestine. Taiwan J Obstet Gynecol. 2018;57(2):319\u201322.","journal-title":"Taiwan J Obstet Gynecol."},{"key":"1064_CR30","first-page":"351","volume":"15","author":"JD Woodruff","year":"1960","unstructured":"Woodruff JD, Novak ER. The Krukenberg tumor: study of 48 cases from the ovarian tumor registry. Obstet Gynecol. 1960;15:351\u201360.","journal-title":"Obstet Gynecol."},{"issue":"3","key":"1064_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/PGP.0000000000000314","volume":"36","author":"J Mitsushita","year":"2017","unstructured":"Mitsushita J, Tanaka A, et al. Metastatic ovarian tumors originating from a small bowel adenocarcinoma\u2013a case report and brief literature review. Int J Gynecol Pathol. 2017;36(3):253\u201360.","journal-title":"Int J Gynecol Pathol"},{"key":"1064_CR32","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","volume":"390","author":"YK Kang","year":"2017","unstructured":"Kang YK, Boku N, Satoh T, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390:2461\u201371.","journal-title":"Lancet"},{"key":"1064_CR33","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (ver. 5)."},{"issue":"1","key":"1064_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/COC.0b013e3182868ec8","volume":"38","author":"V Shahabi","year":"2015","unstructured":"Shahabi V, Postow MA, et al. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy. Am J Clin Oncol. 2015;38(1):90\u20137.","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"1064_CR35","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2217\/imt.15.65","volume":"7","author":"SN Seyedin","year":"2015","unstructured":"Seyedin SN, Schoenhals JE, et al. Strategies for combining immunotherapy with radiation for anticancer therapy. Immunotherapy. 2015;7(9):967\u201380.","journal-title":"Immunotherapy."},{"key":"1064_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejca.2016.06.015","volume":"65","author":"MI Hecht","year":"2016","unstructured":"Hecht MI, B\u00fcttner-Herold M, et al. PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis. Eur J Cancer. 2016;65:52\u201360.","journal-title":"Eur J Cancer."},{"key":"1064_CR37","doi-asserted-by":"crossref","unstructured":"De Wolf K, Kruse V, et al. A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response. J Transl Med. 2017;31;15(1):21.","DOI":"10.1186\/s12967-017-1123-x"},{"issue":"26","key":"1064_CR38","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509\u201320.","journal-title":"N Engl J Med."},{"issue":"9","key":"1064_CR39","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim ST, Cristescu R, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24(9):1449\u201358.","journal-title":"Nat Med."}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-019-01064-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-019-01064-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-019-01064-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T01:02:10Z","timestamp":1604624530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-019-01064-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1007\/s12328-019-01064-9","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"assertion":[{"value":"17 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/animal rights"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}